UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051315
Receipt number R000058534
Scientific Title Smartphone Acceptance and commitment therapy to Keep mind sUpple for Relief of post mAstectomy pain syndrome in breast cancer patients: A randomized controlled trial using an innovative decentralized platform (preliminary study)
Date of disclosure of the study information 2023/06/12
Last modified on 2023/06/12 06:23:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Smartphone Acceptance and commitment therapy to Keep mind sUpple for Relief of post mAstectomy pain syndrome in breast cancer patients: A randomized controlled trial using an innovative decentralized platform (preliminary study)

Acronym

Smartphone Acceptance and commitment therapy to Keep mind sUpple for Relief of post mAstectomy pain syndrome in breast cancer patients (SAKURA Project)

Scientific Title

Smartphone Acceptance and commitment therapy to Keep mind sUpple for Relief of post mAstectomy pain syndrome in breast cancer patients: A randomized controlled trial using an innovative decentralized platform (preliminary study)

Scientific Title:Acronym

Smartphone Acceptance and commitment therapy to Keep mind sUpple for Relief of post mAstectomy pain syndrome in breast cancer patients (SAKURA Project)

Region

Japan


Condition

Condition

Breast cancer

Classification by specialty

Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We conduct a randomized controlled trial to verify the effectiveness of smartphone ACT for PMPS. At the same time, we will develop a fully decentralized clinical trial infrastructure that allows patients to participate in trials without the need to visit the hospital and to obtain patient-reported outcomes remotely. This study examines feasibility and preliminary utility in a small pilot study.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Feasibility

Key secondary outcomes

Preliminary usefulness

Pain Intensity and Disability: Brief Pain Inventory (BPI)
Intensity of fatigue and numbness: M.D.Anderson Symptom Inventory (MDASI)
Pain Acceptance: Chronic Pain Acceptance Questionnaire (CPAQ)
Fear of recurrence: Fear of Cancer Recurrence Inventory-short form: (FCRI-SF)
Work Productivity: Work Productivity and Activity Impairment Questionnaire (WPAI)
Anxiety/depression: Hospital Anxiety and Depression Scale (HADS)
Psychological Flexibility: Acceptance and Action Questionnaire 2: (AAQ-2)
Acting on Values: Valuing Questionnaire (VQ)
Quality of Life: EuroQol-5-Deimensions (EQ5D)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Eight-week smartphone cognitive-behavioral therapy for post-mastectomy pain syndrome in breast cancer patients

Interventions/Control_2

Usual treatment group

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1. Have been diagnosed with breast cancer
2. Patients with no recurrence more than 1 year after breast cancer surgery
3. 18 years old or older at the time of obtaining consent
4. Having PMPS (postoperative pain in the surgical site, armpit, arm on the side of surgery), or site related to reconstructive surgery (reconstructive site and back or abdomen undergoing surgery for reconstruction, etc.) ) pain persists 1 year after reconstructive surgery
5. Smartphone users: Patients who can install the app by themselves on Android or iOS mobile terminals that can use the app and can use it during the study period (OS version: iOS 13.0 or higher, Android 6.0 or higher)

Key exclusion criteria

1. Cannot read or write Japanese
2. Patients who have pain caused by causes other than cancer and are receiving treatment.
3. Patients who have pain in areas other than wounds, armpits, and arms and are undergoing treatment.
4. Patients with mental symptoms that the investigator/co-investigator judges inappropriate for participation, such as dementia/cognitive dysfunction, severe depression with suicidal ideation, poorly controlled schizophrenia, and schizoaffective disorder.
5. Patients who have serious physical diseases (serious respiratory diseases, cardiovascular diseases, central/peripheral nerve diseases, muscular/skeletal diseases, etc.) and are difficult to receive psychological therapy.
6. Patients who have received ACT in the past
7. Other patients who are judged to be inappropriate by the researcher/co-investigator

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Tatsuo
Middle name
Last name Akechi

Organization

Nagoya City University Graduate School of Medical Sciences

Division name

Dept. of Psychiatry and cognitive Behavioral Medicine

Zip code

4678601

Address

Mizuho-cho, Mizuho-ku Nagoya Aichi

TEL

052-853-8271

Email

takechi@med.nagoya-cu.ac.jp


Public contact

Name of contact person

1st name Tatsuo
Middle name
Last name Akechi

Organization

Nagoya City University Graduate School of Medical Sciences

Division name

Dept. of Psychiatry and cognitive Behavioral Medicine

Zip code

4678601

Address

Mizuho-cho, Mizuho-ku Nagoya Aichi

TEL

052-853-8271

Homepage URL

https://sakura-pj.org/about/

Email

takechi@med.nagoya-cu.ac.jp


Sponsor or person

Institute

Nagoya City University Graduate School of Medical Sciences

Institute

Department

Personal name

Tatsuo Akechi


Funding Source

Organization

Japan Agency for Medical Research and Development Research Fund

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagoya City University Ethics Research Review Committee

Address

Mizuho-cho, Mizuho-ku, Nagoya, Aichi Japan

Tel

052-853-8346

Email

rinshou-kenkyu@med.nagoya-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

名古屋市立大学病院


Other administrative information

Date of disclosure of the study information

2023 Year 06 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 12 Month 28 Day

Date of IRB

2023 Year 04 Month 27 Day

Anticipated trial start date

2023 Year 06 Month 12 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 06 Month 10 Day

Last modified on

2023 Year 06 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058534


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name